Bgm (BGM) Non-Current Deffered Revenue (2019 - 2025)

Bgm's (BGM) quarterly Non-Current Deffered Revenue came in at $240154.0 in Q3 2025, up 78.69% year-on-year from $134394.0 in Q3 2024, and up 0.96% on a QoQ basis from $237869.0 in Q1 2025.

Bgm (BGM) Non-Current Deffered Revenue (2019 - 2025) Analysis & Trends

Bgm (BGM) has 7 years of Non-Current Deffered Revenue data on file, last reported at $240154.0 in Q3 2025.

  • On a quarterly basis, Non-Current Deffered Revenue rose 78.69% year-over-year to $240154.0 in Q3 2025; TTM through Sep 2025 was $240154.0, a 78.69% increase from a year earlier, with the FY2025 full-year figure at $240154.0, up 78.69% from the prior year.
  • Non-Current Deffered Revenue for Q3 2025 stood at $240154.0, up from $237869.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for BGM reached as high as $386.3 billion in Q1 2022 and fell as low as $134394.0 in Q3 2024.
  • Historically, Non-Current Deffered Revenue has averaged $72.7 billion across 5 years, with a median of $240154.0 in 2025.
  • Across the five-year window, Non-Current Deffered Revenue slumped 100.0% in 2024 and jumped 78.69% in 2025, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $403745.0 in 2021, then declined by 23.23% to $309943.0 in 2022, then retreated by 28.41% to $221879.0 in 2023, then tumbled by 39.43% to $134394.0 in 2024, then soared by 78.69% to $240154.0 in 2025.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $240154.0 in Q3 2025, $237869.0 in Q1 2025, and $134394.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Bgm 33.55 Mn 23.73 Mn - 240,154.00

Historic Data

Download Data
DateValue
Sep 30, 2025 240,154.00
Mar 31, 2025 237,869.00
Sep 30, 2024 134,394.00
Mar 31, 2024 184,328.00
Sep 30, 2023 221,879.00
Mar 31, 2023 267.55 Bn
Sep 30, 2022 309,943.00
Mar 31, 2022 386.34 Bn
Sep 30, 2021 403,745.00
Sep 30, 2020 722,137.00
Sep 30, 2019 972,338.00